IGC Pharma Inc

IGCAMEX · USD
0.27USD0.00 (-2.06%)
115

IGC Pharma Inc (IGC) Covered Calls

As of September 17, 2026, IGC has 2 covered call opportunities in the coming three months. Return ranges from 103.7 to 103.7% until expiration. Annualized return ranges from 242.6 to 582.3%. The nearest expiration is November 20, 2026. Maximum potential profit is $28.

Read more

Running IGC covered calls helps you generate consistent income from IGC Pharma Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on IGC Pharma Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best IGC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if IGC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling IGC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given IGC Pharma Inc covered call is worth writing.

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Income-focused investors, long-term IGC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling IGC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best IGC Pharma Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile92.06% Elevated
  • Market cap (M$)28
  • 52 weeks high-40.00%
  • 52 weeks low12.50%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$6.00
    2122.22% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-13
  • P/E
  • Future P/E
  • EPS (ttm)-0.08
  • EPS growth next 5 years

As of September 17, 2026

2026-11-20650.5085.190.050.1028.00103.70582.34-18.52+0.531,2700.05
2027-02-191560.5085.190.050.1028.00103.70242.64-18.52+0.532,3340.05

As of September 17, 2026

Sell covered calls with the data behind you

Find the best IGC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial